Business description
ADMA Biologics is commercial biopharmaceutical company committed to manufacturing, marketing, and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection.
Management board & Supervisory board
| CEO |
| Adam S. Grossman |
| Management board |
| Brad Tade, Kaitlin Kestenberg, Doug Chambers, Daniel Garcia, Jeffrey Janek, Michael Least, Drew Pantello, Michael Space, Shane Stremming, Jeffrey Gruenglas, John Hafl, Sheri Klostermeyer, Cindy Petersen |
| Supervisory board |
| Steven A. Elms, Jerrold B. Grossman, Adam S. Grossman, Alison C. Finger, Bryant E. Fong, Lawrence P. Guiheen, Young T. Kwon |
Company data
| Name: |
ADMA Biologics, Inc. |
| Address: |
465 State Route 17,Ramsey, New Jersey |
| Phone: |
+1 201-478-5552 |
| Fax: |
+1 201-478-5553 |
| E-mail: |
info@admabio.com
|
| Internet: |
https://www.admabiologics.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
- |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
IR@admabio.com
|
